慢性阻塞性肺病和氣喘設備市場規模、佔有率和成長分析（按產品、適應症、分銷管道和地區）- 產業預測 2025-2032

預計 2023 年全球 COPD 和氣喘設備市場規模將達到 487.8 億美元，並從 2024 年的 511.7 億美元成長到 2032 年的 750.3 億美元，預測期內（2025-2032 年）的複合年成長率為 4.9%。

由於慢性阻塞性肺病(COPD) 和氣喘的盛行率不斷上升、技術進步以及老年人口的不斷增加，肺部藥物輸送裝置市場正在成長。慢性阻塞性肺病的特徵是氣流阻塞，症狀包括呼吸短促和慢性咳嗽，而氣喘的特徵是氣道功能下降和呼吸困難，需要有效的吸入療法。這些設備將液體藥物轉化為氣溶膠顆粒，確保有針對性地輸送以控制這些慢性病。隨著醫療保健提供者尋求創新方法來支持不斷成長的患者群體，氣喘患者數量的急劇增加和對有效管理解決方案的需求正在推動市場成長，凸顯了這些治療設備在呼吸護理中的重要性。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

COPD 和氣喘設備市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 吸入器
  • 藥物粉末吸入器 (DPI)
  • 定量噴霧吸入器(MDI)
  • 緩霧吸入器
• 噴霧器
  • 壓縮機霧化器
  • 超音波霧化器
  • 網狀霧化器

COPD 和氣喘設備市場規模（按適應症和複合年成長率）（2025-2032）

• 市場概況
• 氣喘
• 慢性阻塞性肺病

COPD 和氣喘設備市場規模（按分銷管道和複合年成長率）（2025-2032）

• 市場概況
• 零售藥局
• 醫院
• 網路藥局

慢性阻塞性肺病及氣喘設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• AstraZeneca Plc.（United Kingdom）
• GlaxoSmithKline Plc.（United Kingdom）
• Merck & Co., Inc.（United States）
• Novartis AG（Switzerland）
• 3M Company（United States）
• Baxter International Inc.（United States）
• ResMed Inc.（United States）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Cipla Ltd.（India）
• Omron Healthcare, Inc.（Japan）
• Invacare Corporation（United States）
• Masimo Corporation（United States）
• Nihon Kohden Corporation（Japan）
• Getinge AB（Sweden）
• Smiths Medical（United Kingdom）
• Allied Healthcare Products, Inc.（United States）
• Aerogen Ltd.（Ireland）
• PARI Medical Holding GmbH（Germany）

結論和建議

Global COPD and Asthma Devices Market size was valued at USD 48.78 billion in 2023 and is poised to grow from USD 51.17 billion in 2024 to USD 75.03 billion by 2032, growing at a CAGR of 4.9% during the forecast period (2025-2032).

The market for pulmonary medication delivery devices is on the rise, driven by the increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, as well as technological advancements and a growing elderly population. COPD, characterized by airflow blockage and symptoms like shortness of breath and chronic cough, and asthma, marked by compromised airway function and respiratory distress, necessitate effective inhalation therapies. These devices transform drug solutions into aerosolized particles, ensuring targeted delivery for managing these chronic conditions. The surge in asthma cases and the need for effective management solutions are propelling market growth, as healthcare providers seek innovative ways to support a rising patient population, underlining the importance of these therapeutic devices in respiratory care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Copd And Asthma Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global COPD And Asthma Devices Market Segmental Analysis

Global COPD and Asthma Devices Market is segmented by Product, Indication, Distribution Channel and region. Based on Product, the market is segmented into Inhalers and Nebulizers. Based on Indication, the market is segmented into Asthma and COPD. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospitals and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global COPD And Asthma Devices Market

The global market for COPD and asthma devices is driven by the increasing incidence of various respiratory conditions such as COPD, asthma, and emphysema. There is an escalating demand for effective short-term treatments and rescue medications, particularly during sudden asthma attacks. Furthermore, government initiatives aimed at enhancing awareness of COPD and asthma symptoms, alongside manufacturers' efforts to innovate portable inhalation devices, are expected to contribute to market growth. As respiratory illnesses lead to significant health complications, the advancement of technology in inhalation devices plays a crucial role in addressing these challenges, facilitating both immediate relief and long-term management solutions for affected individuals.

Restraints in the Global COPD And Asthma Devices Market

The global market for COPD and asthma devices faces several restraints that may hinder its growth. Significant factors include the high cost associated with various inhalation devices and treatments, which can limit accessibility for patients. Environmental concerns regarding metered dose inhalers (MDI) also pose challenges. Furthermore, intense price competition among manufacturers can affect profit margins, while declining material quality may compromise the effectiveness of devices. Limited reimbursement options additionally exacerbate the situation, along with the patent expirations of highly profitable medications, creating hurdles for the sustained expansion of the market.

Market Trends of the Global COPD And Asthma Devices Market

The global COPD and asthma devices market is experiencing a significant shift towards digital inhalers, presenting substantial opportunities for clinical pharmacy. These innovative devices not only enable precise delivery of medication directly to the lungs, minimizing systemic side effects, but they also address persistent challenges in treatment, such as poor adherence and improper usage. As healthcare providers increasingly recognize the importance of patient compliance in managing chronic respiratory conditions, digital inhalers equipped with adherence tracking and user-friendly interfaces are gaining traction. This trend is likely to enhance treatment outcomes, reduce exacerbations, and drive market growth as patients seek more effective, technology-enabled management solutions for COPD and asthma.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global COPD and Asthma Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Inhalers
  • Drug Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Soft Mist Inhalers
• Nebulizers
  • Compressor Nebulizers
  • Ultrasonic Nebulizers
  • Mesh Nebulizers

Global COPD and Asthma Devices Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Asthma
• COPD

Global COPD and Asthma Devices Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospitals
• Online Pharmacies

Global COPD and Asthma Devices Market Size & CAGR (2025-2032)

• North America (Product, Indication, Distribution Channel)
  • US
  • Canada
• Europe (Product, Indication, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Indication, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Indication, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Indication, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AstraZeneca Plc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline Plc. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smiths Medical (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allied Healthcare Products, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerogen Ltd. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PARI Medical Holding GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations